Login
- Title:
Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)': Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79-87.
- Document type:
- Published Erratum
- Author(s):
- Kundranda, M; Gracian, A C; Zafar, S F; Meiri, E; Bendell, J; Algül, H; Rivera, F; Ahn, E R; Watkins, D; Pelzer, U; Charu, V; Zalutskaya, A; Kuesters, G; Pipas, J M; Santillana, S; Askoxylakis, V; Ko, A H
- Journal title abbreviation:
- Ann Oncol
- Year:
- 2020
- Journal volume:
- 31
- Journal issue:
- 8
- Fulltext / DOI:
- doi:10.1016/j.annonc.2020.05.011
- Pubmed ID:
- http://view.ncbi.nlm.nih.gov/pubmed/32507672
- Print-ISSN:
- 0923-7534
- TUM Institution:
- Lehrstuhl für Tumormetabolismus (Prof. Algül)
BibTeX